Alcohol comes with built in rules of thumb. A pint after work. A glass of wine with dinner. Decades of research on safe units and daily limits. Cannabis has no such shared culture, even as it becomes part of daily life for millions of people. That gap is fuelling a wave of new research into cannabis and brain health. Much of it is overturning long held assumptions about how the drug affects users of different ages and habits.

Recreational cannabis is now legal in 24 US states and Washington DC. Use has climbed sharply. Roughly 25 million Americans reported using cannabis in the past year in 2002, according to the National Survey on Drug Use and Health. By 2023, that figure had reached nearly 70 million. Daily or near daily use is growing faster than occasional use.

Doctors are noticing the shift too. Emergency departments report rising numbers of patients with confusion, paranoia, rapid heartbeat and dizziness linked to cannabis intoxication. One study found that cases of cannabinoid hyperemesis syndrome, a condition involving severe and repeated vomiting, quadrupled among adults aged 18 to 35 between 2016 and 2022. As legalisation spreads and products grow stronger, scientists are racing to answer a deceptively simple question. How much is too much?

Potency has transformed the debate on cannabis and brain health

Marijuana entered mainstream life in the 1960s wrapped in imagery of rebellion and experimentation. The products people used then bear little resemblance to what is sold today. In the 1970s and 80s, most cannabis flower contained THC in the low single digits. Many commercial products now routinely exceed 20 percent THC. Concentrates such as vape cartridges, waxes and dabs can reach 70 to 90 percent.

THC, or tetrahydrocannabinol, is largely responsible for the intoxicating and sometimes paranoia inducing effects of cannabis. Some researchers believe highly concentrated THC produces larger dopamine surges. It may also cause greater disruption to salience processing, the brain’s system for deciding what deserves attention. A growing number of studies link frequent use of high potency cannabis to altered brain connectivity, working memory deficits and a higher risk of psychosis like symptoms. Younger users and those with existing vulnerabilities appear to carry the greatest risk.

Claims about mental health benefits look overstated

Many adults, older users especially, turn to cannabis for pain, sleep or anxiety. Two recent reviews suggest the evidence behind that decision is thinner than commonly believed. A JAMA Internal Medicine analysis examined existing studies on PTSD, anxiety, depression, ADHD and bipolar disorder. It concluded that current evidence does not support cannabis use for any of them, while warning of substantial risks of adverse effects.

A separate Lancet review covered 54 randomised controlled trials involving almost 2,500 participants. It found some evidence of benefit for insomnia, tics or Tourette’s syndrome, and autism spectrum disorder. The authors described the underlying evidence as generally low quality. Their conclusion was blunt. Routine use of cannabinoids for treating mental health conditions is rarely justified given how limited the evidence base remains.

Cannabis and cognitive function may depend heavily on age

One of the more unexpected findings in recent years is that moderate use in adulthood may not impair thinking as much as once feared. A 2024 study in JAMA Network Open followed middle aged and older adults. It found no major link between moderate use and cognitive decline across several domains after a year, though participants generally used lower potency products less than daily.

Columbia University psychologist Carl Hart has spent decades examining cannabis and cognitive effects. He argues the adult brain may be more resilient than assumed. In one experiment, adult participants could earn money for performing well on a maths test and chose whether to smoke cannabis beforehand. Most opted not to. Hart found that smoking had minimal impact on accuracy in complex tasks, challenging the idea that cannabis inevitably saps motivation or ambition. The finding relates to a single low dose task, though. It says nothing about the mental health, dependence or long term risks set out elsewhere in this research.

A larger 2025 study in JAMA Network Open offers a more nuanced picture. It analysed brain scans from more than 1,000 young adults aged 22 to 36. The clearest cognitive effects appeared among heavy lifetime users, defined as people who had used cannabis more than 1,000 times. This group showed reduced brain activity during working memory tasks. Moderate users showed far fewer differences. Working memory was the only domain, out of seven tested, that showed a statistically significant link to heavy use. The effects may be more targeted than sweeping.

Adolescent brains appear the most vulnerable to cannabis and brain health risks

Studies stretching back decades have found that teenagers who use cannabis regularly tend to earn lower grades and graduate at lower rates. Some researchers call this pattern amotivational syndrome. A JAMA Health Forum study published in February followed roughly 460,000 adolescents aged 13 to 17 into young adulthood. Cannabis use in the previous year was associated with double the risk of later psychotic and bipolar disorders by age 26. A 2025 JAMA Psychiatry study of young adults with cannabis use disorder found alterations in dopamine related brain systems resembling those seen in psychosis.

Cannabis use disorder involves an inability to stop using despite psychological dependence and withdrawal symptoms. The Centers for Disease Control and Prevention estimates that 3 in 10 people who use cannabis develop the disorder. Harvard Medical School psychobiology professor Bertha Madras has studied adolescent brain development for years. She points to the teenage years as a period when neural connections are rapidly formed, strengthened and pruned. Brain imaging research has linked cannabis use before age 16 to changes in white matter, the pathways that let different brain regions communicate. A 2021 paper found small IQ declines among youths who used frequently.

Madras also ran studies involving adolescent rats and primates given daily cannabis exposure comparable to human use. She found pronounced inflammation in a brain region tied to emotional regulation and stress control. As she put it, “We didn’t see it in the adult brain. It was only the adolescent brain.” Her team believes this may help explain why the drug appears to carry sharper risks for younger users than for adults.

Stopping, not simply cutting back, allows some recovery

Tolerance is one reason use tends to escalate over time. As the body becomes less responsive to THC, people need larger amounts to feel the same effects. Many long term users find their usual dose feels weaker even as consumption rises.

What the evidence shows is that stopping altogether, rather than moderating, is what tends to drive improvement. A 2021 review in Current Behavioral Neuroscience Reports found that some deficits linked to cannabis use may improve after sustained abstinence. Attention and working memory showed the clearest gains, especially among adults and lighter users. A 2018 study in the Journal of the International Neuropsychological Society found that adolescents and young adults who abstained for two weeks showed measurable improvements in attention. Brain imaging studies have found something similar. Altered connectivity patterns in heavy users may partially normalise after a period without use, particularly in networks tied to executive function, reward processing and emotional regulation. None of this proves every change is reversible, and none of it was measured in people who simply cut down. The recovery evidence points to abstinence, not moderation.

Early signs of protection in older brains

Some scientists are exploring whether certain cannabinoids might help protect ageing brains. The theory centres on reducing inflammation and cellular stress, both linked to diseases such as Alzheimer’s and Parkinson’s. The evidence so far is early and comes mostly from laboratory work rather than human trials.

A 2024 study from the Salk Institute focused on cannabinol, or CBN, a compound that forms as THC ages and breaks down. Researchers used mouse neurons, human brain cell cultures and fruit fly models. CBN appeared to protect neurons by preserving mitochondrial function and reducing oxidative stress, both processes implicated in neurodegenerative disease. The findings have generated interest. Scientists are careful to note the work is far from proving that cannabis derived products can prevent dementia or Parkinson’s disease in humans.

Rules do not remove the risk to cannabis and brain health

Not everyone who uses cannabis develops problematic patterns, and researchers have looked at what separates those who do from those who do not. Drexel University’s Stephen Lankenau examined nine years of data on young cannabis users in Los Angeles. Most fell into an uncontrolled group who used without consistent self imposed rules. A smaller group followed rules such as not using before work or school and not driving while high. This group used less frequently and showed fewer signs of problematic use.

The finding is often presented as evidence for a controlled use model. Rules, rather than avoidance, are treated as the main safeguard. But rules did not remove risk in Lankenau’s data. They only reduced how often it showed up, and the less often young people used cannabis, the fewer problems they showed. Set against everything else the research shows, from adolescent vulnerability to the absence of any established safe threshold, the more cautious reading is clear. Avoiding early or heavy use protects brain health more reliably than managing it.

Taken together, the research paints a picture that is far more layered than either side of the legalisation debate tends to admit. Age, frequency and potency all shape outcomes, and none of the evidence points to a pattern of use that is risk free. The science is still catching up with a market that has changed faster than the culture around it. Until it does, avoiding cannabis, particularly during adolescence and periods of heavy use, remains the clearest way to protect brain health.

Source: washingtonpost